152 related articles for article (PubMed ID: 1314713)
1. The reversal of cisplatin-protein interactions by the modulating agent WR2721 and its metabolites WR1065 and WR33278.
Treskes M; Holwerda U; Nijtmans LG; Pinedo HM; van der Vijgh WJ
Cancer Chemother Pharmacol; 1992; 29(6):467-70. PubMed ID: 1314713
[TBL] [Abstract][Full Text] [Related]
2. Effects of the modulating agent WR2721 and its main metabolites on the formation and stability of cisplatin-DNA adducts in vitro in comparison to the effects of thiosulphate and diethyldithiocarbamate.
Treskes M; Nijtmans LG; Fichtinger-Schepman AM; van der Vijgh WJ
Biochem Pharmacol; 1992 Mar; 43(5):1013-9. PubMed ID: 1313234
[TBL] [Abstract][Full Text] [Related]
3. The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin.
Treskes M; Holwerda U; Klein I; Pinedo HM; van der Vijgh WJ
Biochem Pharmacol; 1991 Nov; 42(11):2125-30. PubMed ID: 1659819
[TBL] [Abstract][Full Text] [Related]
4. Cytostatic activity of cisplatin in the presence of WR2721 and its thiol metabolite WR1065 in OVCAR-3 human ovarian cancer cells as compared to V79 fibroblasts.
Treskes M; Nijtmans L; Fichtinger-Schepman AM; van der Vijgh WJ
Anticancer Res; 1992; 12(6B):2261-5. PubMed ID: 1338281
[TBL] [Abstract][Full Text] [Related]
5. Regeneration experiments of the platinated enzyme fumarase, using sodium diethyldithiocarbamate, thiourea, and sodium thiosulfate.
Boelrijk A; Boogaard PJ; Lempers EL; Reedijk J
J Inorg Biochem; 1991 Jan; 41(1):17-24. PubMed ID: 1850448
[TBL] [Abstract][Full Text] [Related]
6. Time dependence of the selective modulation of cisplatin-induced nephrotoxicity by WR2721 in the mouse.
Treskes M; Boven E; Holwerda U; Pinedo HM; van der Vijgh WJ
Cancer Res; 1992 Apr; 52(8):2257-60. PubMed ID: 1313740
[TBL] [Abstract][Full Text] [Related]
7. WR2721 as a modulator of cisplatin- and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach.
Treskes M; van der Vijgh WJ
Cancer Chemother Pharmacol; 1993; 33(2):93-106. PubMed ID: 8261581
[TBL] [Abstract][Full Text] [Related]
8. Protection against cis-diamminedichloroplatinum cytotoxicity and mutagenicity in V79 cells by 2-[(aminopropyl)amino]ethanethiol.
Nagy B; Dale PJ; Grdina DJ
Cancer Res; 1986 Mar; 46(3):1132-5. PubMed ID: 3943091
[TBL] [Abstract][Full Text] [Related]
9. The chemical reactivity of BNP7787 and its metabolite mesna with the cytostatic agent cisplatin: comparison with the nucleophiles thiosulfate, DDTC, glutathione and its disulfide GSSG.
Verschraagen M; Kedde MA; Hausheer FH; Van Der Vijgh WJ
Cancer Chemother Pharmacol; 2003 Jun; 51(6):499-504. PubMed ID: 12715205
[TBL] [Abstract][Full Text] [Related]
10. The comparative effects of sodium thiosulfate, diethyldithiocarbamate, fosfomycin and WR-2721 on ameliorating cisplatin-induced ototoxicity.
Church MW; Kaltenbach JA; Blakley BW; Burgio DL
Hear Res; 1995 Jun; 86(1-2):195-203. PubMed ID: 8567417
[TBL] [Abstract][Full Text] [Related]
11. The cytoprotective aminothiol WR1065 activates p21waf-1 and down regulates cell cycle progression through a p53-dependent pathway.
North S; El-Ghissassi F; Pluquet O; Verhaegh G; Hainaut P
Oncogene; 2000 Feb; 19(9):1206-14. PubMed ID: 10713709
[TBL] [Abstract][Full Text] [Related]
12. In vitro protection from cisplatin-induced neurotoxicity by amifostine and its metabolite WR1065.
Verstappen CC; Geldof AA; Postma TJ; Heimans JJ
J Neurooncol; 1999 Aug; 44(1):1-5. PubMed ID: 10582662
[TBL] [Abstract][Full Text] [Related]
13. Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
Carfagna PF; Chaney SG; Chang J; Holbrook DJ
Fundam Appl Toxicol; 1990 May; 14(4):706-19. PubMed ID: 2163338
[TBL] [Abstract][Full Text] [Related]
14. Relationship between phosphorylated histone H2AX formation and cell survival in human microvascular endothelial cells (HMEC) as a function of ionizing radiation exposure in the presence or absence of thiol-containing drugs.
Kataoka Y; Murley JS; Baker KL; Grdina DJ
Radiat Res; 2007 Jul; 168(1):106-14. PubMed ID: 17723002
[TBL] [Abstract][Full Text] [Related]
15. Quiescent LLC-PK1 cells as a model for cis-diamminedichloroplatinum(II) nephrotoxicity and modulation by thiol rescue agents.
Montine TJ; Borch RF
Cancer Res; 1988 Nov; 48(21):6017-24. PubMed ID: 2458831
[TBL] [Abstract][Full Text] [Related]
16. Mammalian cell polyamine homeostasis is altered by the radioprotector WR1065.
Mitchell JL; Rupert J; Leyser A; Judd GG
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):329-34. PubMed ID: 9761731
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate.
Gandara DR; Wiebe VJ; Perez EA; Makuch RW; DeGregorio MW
Crit Rev Oncol Hematol; 1990; 10(4):353-65. PubMed ID: 2177606
[TBL] [Abstract][Full Text] [Related]
18. A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate.
Andrews PA; Wung WE; Howell SB
Anal Biochem; 1984 Nov; 143(1):46-56. PubMed ID: 6099065
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.
Dedon PC; Borch RF
Biochem Pharmacol; 1987 Jun; 36(12):1955-64. PubMed ID: 2954556
[TBL] [Abstract][Full Text] [Related]
20. HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721).
Thompson DC; Wyrick SD; Holbrook DJ; Chaney SG
Biochem Pharmacol; 1995 Oct; 50(9):1413-9. PubMed ID: 7503792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]